The Federal Trade Commission (FTC) has opened an antitrust inquiry into Epic, the electronic health records (EHR) giant, stirring scrutiny over its control of patient data access and employee movement within the healthcare sector. Investigators have reportedly questioned industry insiders about whether Epic restricts competitors’ access to its data and enforces contracts that limit employees from joining rival companies.
Amid the regulatory pressures, Epic used its annual conference to reveal a suite of new artificial intelligence (AI) solutions aimed at healthcare systems. CEO Judy Faulkner introduced Agent Factory, a platform designed for hospitals to create and oversee customized AI agents. Additionally, Epic launched Cosmos Curiosity, a predictive analytics tool powered by its extensive de-identified patient database that aids clinicians in identifying readmission risks and addressing population health issues.
Epic also showcased advancements in AI-driven clinical support, including a tool that compiles patient data to streamline clinician preparation for appointments. Its AI assistants—Art for clinicians, Emmie for patients, and Penny for revenue cycle management—received expanded functionality to further integrate AI across healthcare workflows.
In response to questions about anticompetitive behavior, Epic emphasized its leadership in data-sharing standards. A company spokesperson noted Epic’s pioneering connection to TEFCA, the federal interoperability network, alongside the availability of over a thousand open APIs that facilitate integration with nearly 3,000 third-party applications.
Despite Epic’s growing footprint in AI and data interoperability, some health technology executives caution against assuming innovation will differentiate solely through feature sets. One industry leader highlighted execution quality, demonstrated outcomes, and cross-system architectural compatibility as the critical measures of lasting value, noting that features will likely converge across platforms.
Another expert pointed out that clinical AI demands rigorous design standards that traditional EHR platforms may not fully support, suggesting specialized health tech companies will continue to carve out distinct roles beyond what Epic’s expansive system offers.
As Epic continues to expand its technology stack under the watchful eye of regulators, competitors and observers alike are watching closely to see how this balance between innovation and antitrust concerns will shape the future of healthcare technology.